• 1
  • 2
  • 3
  • 4
  • Default
  • Title
  • Date
  • Random


  • The largest inventory of fine chemical, standard and pharma grade cyclodextrins derivatives from mg to kg scale, maltooligormes, fluorescent tagged cyclodextrins, single isomers, polymers and special HPLC columns for their qualification.
    Details


  • Commercially available USP N.F. grade Betadex Sulfobutyl Ether Sodium manufactured under cGMP conditions. We also provide corresponding development services and reference materials for the qualification.
    Details


  • Every possible cyclodextrin-related service including custom GMP manufacturing of cyclodextrins, formulation development, custom synthesis of cyclodextrins, related analytical services and many more...
    Details

CycloLab

The world's only all-round CYCLODEXTRIN BIOTECH company

CycloLab Ltd. started its life and operated as a small R&D company for over 25 years. Recent changes in the world market and economy revealed the need for a change in the company’s business portfolio. Hence we have decided to share the resources between R&D activity and establishment of manufacturing facilities that enable the production of cyclodextrins in larger scale and under GMP circumstances.

To maintain and strengthen our position in the market, CycloLab dedicates special attention to invention and developing patentable technologies. This attitude is well highlighted by the over 130 patents filed by the company so far.

CycloLab committed its operations to serve the pharmaceutical industry by participating in early phase drug development studies (feasibility, formulation optimization, bioequivalence, etc) analysis and GMP manufacturing of various cyclodextrin derivatives to be applied as excipients.

News

  • 01-02-2016
    Meridian Labs is a specialty pharmaceutical company focusing on the development of cancer treatments through formulation improvements. Meridian’s proprietary liquid formulation of docetaxel injection for the treatment of multiple form of cancer contains Captisol to eliminate Polysorbate 80. The in-vitro study data from CycloLab submitted to FDA show the pharmacology properties of the new...
  • 01-02-2016
    Novel porous βCD polymer was prepared and used for rapid removal of organic micropollutants from water. The crosslinking agent, tetrafluoroterephthalonitrile ensures rigid structure and high porosity improving the availability of the CD rings within the structure. Even mixtures of emerging contaminants (drugs, hormones, pesticides and endocrine-disrupting chemicals) were efficiently removed in...
  • 01-02-2016
    Vtesse, Inc, a rare disease company, announced that FDA granted Breakthrough Therapy designation to VTS-270 (a proprietary form of HPBCD) for the treatment of children with Niemann-Pick Disease Type C (NPC). The NPC Study, a Phase 2b/3 randomized, sham-controlled clinical trial designed to evaluate the efficacy and safety of VTS-270. Its primary objective is to evaluate the progression of the...
  • 01-02-2016
    Virio Health, LLC announced that it has entered into exclusive license and supply agreement with Ligand Pharmaceuticals, Inc. for Captisol to be used for the development of cannabinoid-based medications. The Captisol formulations are expected to avoid the usual side effects of opioids (death from overdose and debilitating addiction) for the treatment of chronic pain....
  • More news

Events

Contact

CycloLab Cyclodextrin Research and Development Laboratory Ltd.

Location: Illatos út 7, Budapest, Hungary, H-1097

Mail address: Budapest, P.O.Box 435, H-1525 Hungary

Phone: 0036-1-347-6060 or -6070           Fax: 0036-1-347-6068

E-mail: cyclolab@cyclolab.hu

Registered by the Metropolitan Court as court of registration under No. Cg. 01-09-162381

VAT No.: HU 10678970